Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Harding

Showing results (551-560 of 945) with videos related to

Pageof 95
Sort By:
Leukemia|September 8, 2012
Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patientsH Ludwig, D Milosavljevic, N Zojer, et al.
Metabolic Brain Disease|June 1, 1988
Mitochondrial enzymes in hereditary ataxiasK F Sheu, J P Blass, J M Cedarbaum, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2002
Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosisN B Lincoln, A Dent, J Harding, et al.
The Veterinary Record|November 27, 2001
Duration of immunity in cats after vaccination or naturally acquired infectionM J Coyne, J H Burr, T D Yule, et al.
Cell Transplantation|June 5, 2018
Identification and In Vitro Expansion of Buccal Epithelial CellsSoraya Rasi Ghaemi, Bahman Delalat, Frances J Harding, et al.
Ophthalmic Research|January 1, 1996
Molecular masses of gamma-crystallinsM L Riley, J J Harding, G W Kilby, et al.
The Bone & Joint Journal|August 3, 2013
Do intervertebral discs degenerate before they herniate, or after?P Lama, C L Le Maitre, P Dolan, et al.
Phytochemistry|March 25, 2022
Derrisrobustones A-D, isoflavones from the twig extract of Derris robusta (DC.) Benth. and their α-glucosidase inhibitory activityCholpisut Tantapakul, Virayu Suthiphasilp, Apirak Payaka, et al.
Oncology Research and Treatment|March 7, 2023
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 MutationBruno Almeida Costa, Paulino Tallón de Lara, Wungki Park, et al.
Future Oncology (London, England)|November 18, 2022
Tremelimumab and durvalumab in the treatment of unresectable, advanced hepatocellular carcinomaTiago Biachi de Castria, Danny N Khalil, James J Harding, et al.
Pageof 95

Showing results (551-560 of 945) with videos related to

Sort By:
Pageof 95
Leukemia|September 8, 2012
Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patientsH Ludwig, D Milosavljevic, N Zojer, et al.
Metabolic Brain Disease|June 1, 1988
Mitochondrial enzymes in hereditary ataxiasK F Sheu, J P Blass, J M Cedarbaum, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2002
Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosisN B Lincoln, A Dent, J Harding, et al.
The Veterinary Record|November 27, 2001
Duration of immunity in cats after vaccination or naturally acquired infectionM J Coyne, J H Burr, T D Yule, et al.
Cell Transplantation|June 5, 2018
Identification and In Vitro Expansion of Buccal Epithelial CellsSoraya Rasi Ghaemi, Bahman Delalat, Frances J Harding, et al.
Ophthalmic Research|January 1, 1996
Molecular masses of gamma-crystallinsM L Riley, J J Harding, G W Kilby, et al.
The Bone & Joint Journal|August 3, 2013
Do intervertebral discs degenerate before they herniate, or after?P Lama, C L Le Maitre, P Dolan, et al.
Phytochemistry|March 25, 2022
Derrisrobustones A-D, isoflavones from the twig extract of Derris robusta (DC.) Benth. and their α-glucosidase inhibitory activityCholpisut Tantapakul, Virayu Suthiphasilp, Apirak Payaka, et al.
Oncology Research and Treatment|March 7, 2023
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 MutationBruno Almeida Costa, Paulino Tallón de Lara, Wungki Park, et al.
Future Oncology (London, England)|November 18, 2022
Tremelimumab and durvalumab in the treatment of unresectable, advanced hepatocellular carcinomaTiago Biachi de Castria, Danny N Khalil, James J Harding, et al.
Pageof 95